Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Diabetes‐Associated Cognitive Impairment: Pathophysiology and Emerging Therapies. Local targets link to admitted publications; unresolved targets remain external evidence.
Diabetes‐Related Dementia
10.1007/978-981-13-3540-2_8 · 2019 · External reference
Prevalence, Risk Factors, and Early Prediction of Cognitive Impairment in Patients With Diabetes Mellitus: A Systematic Review and Meta‐Analysis
10.3389/fendo.2026.1757367 · 2026 · External reference
Worldwide Trends in Diabetes Prevalence and Treatment From 1990 to 2022: A Pooled Analysis of 1108 Population‐Representative Studies With 141 Million Participants
10.1016/s0140-6736(24)02317-1 · 2024 · External reference
Glucose Indices Are Associated With Cognitive and Structural Brain Measures in Young Adults
10.1212/wnl.0000000000001655 · 2015 · External reference
Cognitive Dysfunction in Diabetes: Abnormal Glucose Metabolic Regulation in the Brain
10.3389/fendo.2023.1192602 · 2023 · External reference
Diabetes: A Risk Factor for Cognitive Impairment and Dementia?
10.1212/wnl.0000000000001671 · 2015 · External reference
The Prevalence of Mild Cognitive Impairment in Type 2 Diabetes Mellitus Patients: A Systematic Review and Meta‐Analysis
10.1007/s00592-020-01648-9 · 2021 · External reference
HbA(1c), Diabetes and Cognitive Decline: The English Longitudinal Study of Ageing
10.1007/s00125-017-4541-7 · 2018 · External reference
Dementia Prevention, Intervention, and Care: 2024 Report of the Lancet Standing Commission
10.1016/s0140-6736(24)01296-0 · 2024 · External reference
Impact of Pharmacological Treatment of Diabetes Mellitus on Dementia Risk: Systematic Review and Meta‐Analysis
10.1136/bmjdrc-2018-000563 · 2018 · External reference
Glycemic Control, Diabetic Complications, and Risk of Dementia in Patients With Diabetes: Results From a Large U.K. Cohort Study
10.2337/dc20-2850 · 2021 · External reference
Effect of the Treatment of Type 2 Diabetes Mellitus on the Development of Cognitive Impairment and Dementia
2017 · External reference
Intensive Blood Glucose Control and Vascular Outcomes in Patients With Type 2 Diabetes
10.1056/nejmoa0802987 · 2008 · External reference
Effects of Intensive Glucose Lowering on Brain Structure and Function in People With Type 2 Diabetes (ACCORD MIND): A Randomised Open‐Label Substudy
10.1016/s1474-4422(11)70188-0 · 2011 · External reference
Diabetes: A Tipping Point in Neurodegenerative Diseases
10.1016/j.molmed.2023.09.005 · 2023 · External reference
Common Pathways in Dementia and Diabetic Retinopathy: Understanding the Mechanisms of Diabetes‐Related Cognitive Decline
10.1016/j.tem.2021.10.008 · 2022 · External reference
Global, Regional, and National Burden of Diabetes From 1990 to 2021, With Projections of Prevalence to 2050: A Systematic Analysis for the Global Burden of Disease Study 2021
10.1016/s0140-6736(23)01301-6 · 2023 · External reference
A Meta‐Analysis of Cognitive Functioning in Nondemented Adults With Type 2 Diabetes Mellitus
10.1016/j.jcjd.2014.01.014 · 2014 · External reference
Cognitive Impairment and MRI Correlates in the Elderly Patients With Type 2 Diabetes Mellitus
10.1093/ageing/afl180 · 2007 · External reference
Brain Magnetic Resonance Imaging Correlates of Impaired Cognition in Patients With Type 2 Diabetes
10.2337/diabetes.55.04.06.db05-1323 · 2006 · External reference
Diabetes and Cognitive Dysfunction
10.1016/s0140-6736(12)60360-2 · 2012 · External reference
Effects of Type 2 Diabetes on 12‐Year Cognitive Change: Results From the Maastricht Aging Study
10.2337/dc12-0746 · 2013 · External reference
Risk of Dementia in Diabetes Mellitus: A Systematic Review
10.1016/s1474-4422(05)70284-2 · 2006 · External reference
Diabetes Mellitus and Risks of Cognitive Impairment and Dementia: A Systematic Review and Meta‐Analysis of 144 Prospective Studies
10.1016/j.arr.2019.100944 · 2019 · External reference
Impact of Cardiometabolic Conditions on the Progression From Mild Cognitive Impairment to Dementia: A Large Cohort Study
10.1002/alz.70692 · 2025 · External reference
Twelve‐Year Nationwide Cohort Study Identifying Risk Factors for Conversion From Mild Cognitive Impairment to Alzheimer's Disease
10.1038/s41598-025-16620-2 · 2025 · External reference
Conversion of Mild Cognitive Impairment to Dementia Among Subjects With Diabetes: A Population‐Based Study of Incidence and Risk Factors With Five Years of Follow‐Up
10.3233/jad-141566 · 2015 · External reference
Diabetes Mellitus, Prediabetes and the Risk of Parkinson's Disease: A Systematic Review and Meta‐Analysis of 15 Cohort Studies With 29.9 Million Participants and 86,345 Cases
10.1007/s10654-023-00970-0 · 2023 · External reference
Type 2 Diabetes as a Determinant of Parkinson's Disease Risk and Progression
10.1002/mds.28551 · 2021 · External reference
Risk Factors for Dementia With Lewy Bodies: A Case‐Control Study
10.1212/wnl.0b013e3182a2cbd1 · 2013 · External reference
Metabolic Risk Factors of Alzheimer's Disease, Dementia With Lewy Bodies, and Normal Elderly: A Population‐Based Study
10.1155/2018/8312346 · 2018 · External reference
Association of Cardiovascular Disease Management Drugs With Lewy Body Dementia: A Case‐Control Study
10.1093/braincomms/fcad346 · 2024 · External reference
Diabetes in a Large Dementia Cohort: Clinical Characteristics and Treatment From the Swedish Dementia Registry
10.2337/dc16-2516 · 2017 · External reference
Cardiovascular Risk Factors and Frontotemporal Dementia: A Case‐Control Study
10.1186/2047-9158-3-13 · 2014 · External reference
Meta‐Analyses of Structural Regional Cerebral Effects in Type 1 and Type 2 Diabetes
10.1007/s11682-014-9348-2 · 2015 · External reference
Spatial Patterns of Structural Brain Changes in Type 2 Diabetic Patients and Their Longitudinal Progression With Intensive Control of Blood Glucose
10.2337/dc14-1196 · 2015 · External reference
The Association of Prediabetes and Type 2 Diabetes With Hippocampal Subfields Volume: The Maastricht Study
10.1016/j.nicl.2023.103455 · 2023 · External reference
Cerebral Microvascular Complications of Type 2 Diabetes: Stroke, Cognitive Dysfunction, and Depression
10.1016/s2213-8587(19)30405-x · 2020 · External reference
Understanding Multifactorial Brain Changes in Type 2 Diabetes: A Biomarker Perspective
10.1016/s1474-4422(20)30139-3 · 2020 · External reference
White Matter Hyperintensities and Alzheimer's Disease: An Alternative View of an Alternative Hypothesis
10.1002/alz.13371 · 2023 · External reference
White Matter Hyperintensities in Alzheimer's Disease: Beyond Vascular Contribution
10.1002/alz.13057 · 2023 · External reference
Does Cerebral Small Vessel Disease Predict Future Decline of Cognitive Function in Elderly People With Type 2 Diabetes?
10.1016/j.diabres.2011.06.014 · 2011 · External reference
Endothelial and Inflammatory Markers in Relation to Progression of Ischaemic Cerebral Small‐Vessel Disease and Cognitive Impairment: A 6‐Year Longitudinal Study in Patients With Type 2 Diabetes Mellitus
10.1136/jnnp.2010.217380 · 2011 · External reference
A Diffusion Tensor Imaging Study on White Matter Abnormalities in Patients With Type 2 Diabetes Using Tract‐Based Spatial Statistics
10.3174/ajnr.a4740 · 2016 · External reference
Reorganization of Brain Networks in Aging: A Review of Functional Connectivity Studies
10.3389/fpsyg.2015.00663 · 2015 · External reference
Brain Functional Alterations in Type 2 Diabetes—A Systematic Review of fMRI Studies
10.1016/j.yfrne.2017.07.001 · 2017 · External reference
Impaired Cerebral Blood Flow in Type 2 Diabetes Mellitus—A Comparative Study With Subjective Cognitive Decline, Vascular Dementia and Alzheimer's Disease Subjects
10.1016/j.nicl.2020.102302 · 2020 · External reference
Cerebral Blood Flow, Blood Supply, and Cognition in Type 2 Diabetes Mellitus
10.1038/s41598-016-0003-6 · 2016 · External reference
Cerebral Blood Flow Alterations in Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Arterial Spin Labeling Studies
10.3389/fnagi.2022.847218 · 2022 · External reference
The Role of Neurovascular Coupling Dysfunction in Cognitive Decline of Diabetes Patients
10.3389/fnins.2024.1375908 · 2024 · External reference
From Metabolic Dysregulation to Neurodegenerative Pathology: The Role of Hyperglycemia, Oxidative Stress, and Blood‐Brain Barrier Breakdown in T2D‐Driven Alzheimer's Disease
10.1007/s11011-025-01700-z · 2025 · External reference
Cognitive Dysfunction: A Growing Link Between Diabetes and Alzheimer's Disease
10.1002/ddr.21579 · 2020 · External reference
Cerebrovascular Complications of Diabetes: Focus on Cognitive Dysfunction
10.1042/cs20160397 · 2016 · External reference
Comparison of Brachial Artery Flow‐Mediated Dilation in Youth With Type 1 and Type 2 Diabetes Mellitus
10.1111/jdi.12191 · 2014 · External reference
Endothelial Dysfunction in Vascular Complications of Diabetes: A Comprehensive Review of Mechanisms and Implications
10.3389/fendo.2024.1359255 · 2024 · External reference
Transendothelial Glucose Transport Is Not Restricted by Extracellular Hyperglycaemia
10.1016/j.vph.2016.11.001 · 2016 · External reference
Advanced Glycation End Products Activate Endothelium Through Signal‐Transduction Receptor RAGE: A Mechanism for Amplification of Inflammatory Responses
10.1161/hc0702.104183 · 2002 · External reference
Glycation of LDL: AGEs, Impact on Lipoprotein Function, and Involvement in Atherosclerosis
10.3389/fcvm.2023.1094188 · 2023 · External reference
Aging and Glycation Promote Erythrocyte Phagocytosis by Human Endothelial Cells: Potential Impact in Atherothrombosis Under Diabetic Conditions
10.1016/j.atherosclerosis.2019.10.015 · 2019 · External reference
Endothelial‐To‐Mesenchymal Transition: An Underappreciated Mediator of Diabetic Complications
10.3389/fendo.2023.1050540 · 2023 · External reference
2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS Guideline on the Management of Patients With Extracranial Carotid and Vertebral Artery Disease: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in Collaboration With the American Academy of Neurology and Society of Cardiovascular Computed Tomography
10.1002/ccd.22983 · 2013 · External reference
Risk Factors for Intracranial Atherosclerosis: A Systematic Review and Meta‐Analysis
10.1016/j.atherosclerosis.2018.12.015 · 2019 · External reference
Diabetes Mellitus, Fasting Blood Glucose Concentration, and Risk of Vascular Disease: A Collaborative Meta‐Analysis of 102 Prospective Studies
10.1016/s0140-6736(10)60484-9 · 2010 · External reference
Neurovascular Coupling in Type 2 Diabetes With Cognitive Decline. A Narrative Review of Neuroimaging Findings and Their Pathophysiological Implications
10.3389/fendo.2022.874007 · 2022 · External reference
Changes in Hemodynamic Response Function Components Reveal Specific Changes in Neurovascular Coupling in Type 2 Diabetes
10.3389/fphys.2022.1101470 · 2022 · External reference
Neurovascular Coupling in Patients With Type 2 Diabetes Mellitus
10.3389/fnagi.2022.976340 · 2022 · External reference
Neurovascular Decoupling in Type 2 Diabetes Mellitus Without Mild Cognitive Impairment: Potential Biomarker for Early Cognitive Impairment
10.1016/j.neuroimage.2019.06.058 · 2019 · External reference
Neurovascular Decoupling Measured With Quantitative Susceptibility Mapping Is Associated With Cognitive Decline in Patients With Type 2 Diabetes
10.1093/cercor/bhac422 · 2023 · External reference
Neurovascular Coupling Is Impaired in Hypertensive and Diabetic Subjects Without Symptomatic Cerebrovascular Disease
10.3389/fnagi.2021.728007 · 2021 · External reference
Neurovascular Coupling Alterations in Type 2 Diabetes: A 5‐Year Longitudinal MRI Study
10.1136/bmjdrc-2020-001433 · 2021 · External reference
Association of Orthostatic Hypotension With Incident Dementia, Stroke, and Cognitive Decline
10.1212/wnl.0000000000006027 · 2018 · External reference
Population‐Based Study on the Prevalence and Risk Factors of Orthostatic Hypotension in Subjects With Pre‐Diabetes and Diabetes
10.2337/dc08-1389 · 2009 · External reference
Prevalence, Risk Factors, and Prognosis of Orthostatic Hypotension in Diabetic Patients: A Systematic Review and Meta‐Analysis
10.1097/md.0000000000008004 · 2017 · External reference
Effects of Orthostatic Hypotension on Cognition in Type 2 Diabetes Mellitus
10.1002/ana.25578 · 2019 · External reference
Orthostatic Hypotension Promotes the Progression From Mild Cognitive Impairment to Dementia in Type 2 Diabetes Mellitus
10.1210/clinem/dgad764 · 2024 · External reference
Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition
10.1007/s11481-017-9752-7 · 2017 · External reference
Alzheimer's Disease: A Matter of Blood‐Brain Barrier Dysfunction?
10.1084/jem.20171406 · 2017 · External reference
Blood‐Brain Barrier Dysfunction Amplifies the Development of Neuroinflammation: Understanding of Cellular Events in Brain Microvascular Endothelial Cells for Prevention and Treatment of BBB Dysfunction
10.3389/fncel.2021.661838 · 2021 · External reference
Brain Insulin Resistance in Type 2 Diabetes and Alzheimer Disease: Concepts and Conundrums
10.1038/nrneurol.2017.185 · 2018 · External reference
Cognitive Disorder and Dementia in Type 2 Diabetes Mellitus
10.4239/wjd.v13.i4.319 · 2022 · External reference
Brain Insulin Responsiveness Is Linked to Age and Peripheral Insulin Sensitivity
10.1111/dom.15094 · 2023 · External reference
Role of the Blood‐Brain Barrier in Central Nervous System Insulin Resistance
10.3389/fnins.2019.00521 · 2019 · External reference
Effect of Diabetes Mellitus on the Permeability of the Blood‐Brain Barrier to Insulin
10.1016/s0196-9781(97)00238-6 · 1997 · External reference
Evidence for Altered Transport of Insulin Across the Blood‐Brain Barrier in Insulin‐Resistant Humans
10.1007/s00592-013-0546-y · 2014 · External reference
The Expression of Insulin in the Central Nervous System: What Have we Learned So Far?
10.3390/ijms24076586 · 2023 · External reference
Insulin Stimulates Atypical Protein Kinase C‐Mediated Phosphorylation of the Neuronal Adaptor FE65 to Potentiate Neurite Outgrowth by Activating ARF6‐Rac1 Signaling
10.1096/fj.202200757r · 2022 · External reference
Insulin and Its Key Role for Mitochondrial Function/Dysfunction and Quality Control: A Shared Link Between Dysmetabolism and Neurodegeneration
10.3390/biology11060943 · 2022 · External reference
Untangling the Effect of Insulin Action on Brain Mitochondria and Metabolism
10.1111/jne.12932 · 2021 · External reference
Deficient Brain Insulin Signalling Pathway in Alzheimer's Disease and Diabetes
10.1002/path.2912 · 2011 · External reference
Impaired Insulin and Insulin‐Like Growth Factor Expression and Signaling Mechanisms in Alzheimer's Disease—Is This Type 3 Diabetes?
10.3233/jad-2005-7107 · 2005 · External reference
Abnormal Serine Phosphorylation of Insulin Receptor Substrate 1 Is Associated With Tau Pathology in Alzheimer's Disease and Tauopathies
10.1007/s00401-014-1328-5 · 2014 · External reference
An Anti‐Diabetes Agent Protects the Mouse Brain From Defective Insulin Signaling Caused by Alzheimer's Disease‐Associated Abeta Oligomers
10.1172/jci57256 · 2012 · External reference
Demonstrated Brain Insulin Resistance in Alzheimer's Disease Patients Is Associated With IGF‐1 Resistance, IRS‐1 Dysregulation, and Cognitive Decline
10.1172/jci59903 · 2012 · External reference
A Systematic Review of In Vivo Brain Insulin Resistance Biomarkers in Humans
10.1016/j.bionps.2025.100125 · 2025 · External reference
Insulin Resistance and Alzheimer‐Like Reductions in Regional Cerebral Glucose Metabolism for Cognitively Normal Adults With Prediabetes or Early Type 2 Diabetes
10.1001/archneurol.2010.225 · 2011 · External reference
Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle‐Aged Adults at Risk for Alzheimer Disease
10.1001/jamaneurol.2015.0613 · 2015 · External reference
A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease
10.3389/fnins.2021.626636 · 2021 · External reference
Lower GLUT1 and Unchanged MCT1 in Alzheimer's Disease Cerebrovasculature
10.1177/0271678x241237484 · 2024 · External reference
Type 2 Diabetes and Biomarkers of Brain Structure, Perfusion, Metabolism, and Function in Late Mid‐Life: A Multimodal Discordant Twin Study
10.3233/jad-230640 · 2024 · External reference
Relationships Between Brain Glucose Metabolism Patterns and Impaired Glycemic Status: A Systematic Review of FDG‐PET Studies With a Focus on Alzheimer's Disease
10.1002/hbm.70180 · 2025 · External reference
18FDG PET in Vascular Dementia: Differentiation From Alzheimer's Disease Using Voxel‐Based Multivariate Analysis
10.1038/sj.jcbfm.9600296 · 2006 · External reference
Brain Glucose Metabolism in Vascular White Matter Disease With Dementia: Differentiation From Alzheimer Disease
10.1161/strokeaha.110.591552 · 2010 · External reference
Type 2 Diabetes Mellitus Is Associated With Brain Atrophy and Hypometabolism in the ADNI Cohort
10.1212/wnl.0000000000002950 · 2016 · External reference
Diabetes and Elevated Hemoglobin A1c Levels Are Associated With Brain Hypometabolism but Not Amyloid Accumulation
10.2967/jnumed.113.132647 · 2014 · External reference
Astrocytic GLUT1 Reduction Paradoxically Improves Central and Peripheral Glucose Homeostasis
10.1126/sciadv.adp1115 · 2024 · External reference
GLUT1 Reductions Exacerbate Alzheimer's Disease Vasculo‐Neuronal Dysfunction and Degeneration
10.1038/nn.3966 · 2015 · External reference
Brain Glucose Transporters: Implications for Neurologic Disease
10.1212/wnl.0000000000000328 · 2014 · External reference
GLUT4 Mobilization Supports Energetic Demands of Active Synapses
10.1016/j.neuron.2016.12.020 · 2017 · External reference
Insulin Modulates Hippocampally‐Mediated Spatial Working Memory via Glucose Transporter‐4
10.1016/j.bbr.2017.09.033 · 2018 · External reference
Transcriptional Regulation of the Insulin‐Responsive Glucose Transporter GLUT4 Gene: From Physiology to Pathology
10.1152/ajpendo.90306.2008 · 2008 · External reference
Decreased Glucose Transporters Correlate to Abnormal Hyperphosphorylation of Tau in Alzheimer Disease
10.1016/j.febslet.2007.12.035 · 2008 · External reference
Evidence for Brain Glucose Dysregulation in Alzheimer's Disease
10.1016/j.jalz.2017.09.011 · 2018 · External reference
Amyloid Beta Peptides Inhibit Glucose Transport at the Blood‐Brain Barrier by Disrupting the Insulin‐AKT Pathway
10.1177/0271678x251332493 · 2025 · External reference
Blunted Rise in Brain Glucose Levels During Hyperglycemia in Adults With Obesity and T2DM
10.1172/jci.insight.95913 · 2017 · External reference
Down‐Regulation of Blood‐Brain Glucose Transport in the Hyperglycemic Nonobese Diabetic Mouse
10.1007/bf00969700 · 1995 · External reference
Glucose Transporter 1 Is Essential to Maintain Brain Endothelial Cell Homeostasis Under Hyperglycemia Condition
10.1152/ajpcell.00615.2024 · 2025 · External reference
Blood‐Brain Barrier Glucose Transporter: Effects of Hypo‐ and Hyperglycemia Revisited
10.1046/j.1471-4159.1999.0720238.x · 1999 · External reference
Diabetes, Alzheimer Disease, and Vascular Dementia: A Population‐Based Neuropathologic Study
10.1212/wnl.0b013e3181f4d7f8 · 2010 · External reference
Diabetes Is Related to Cerebral Infarction but Not to AD Pathology in Older Persons
10.1212/01.wnl.0000247053.45483.4e · 2006 · External reference
Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology
10.1093/gerona/60.4.471 · 2005 · External reference
Diabetics Do Not Have Increased Alzheimer‐Type Pathology Compared With Age‐Matched Control Subjects. A Retrospective Postmortem Immunocytochemical and Histofluorescent Study
10.1212/wnl.49.5.1306 · 1997 · External reference
Increased Risk of Type 2 Diabetes in Alzheimer Disease
10.2337/diabetes.53.2.474 · 2004 · External reference
Human Cerebral Neuropathology of Type 2 Diabetes Mellitus
10.1016/j.bbadis.2008.08.005 · 2009 · External reference
Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies: The Honolulu‐Asia Aging Study
10.2337/diabetes.51.4.1256 · 2002 · External reference
Review: Relationship of Type 2 Diabetes to Human Brain Pathology
10.1111/nan.12476 · 2018 · External reference
Beta‐Amyloid Deposition in Brains of Subjects With Diabetes
10.1111/j.1365-2990.2008.00948.x · 2009 · External reference
Different Patterns of Cerebral Injury in Dementia With or Without Diabetes
10.1001/archneurol.2008.579 · 2009 · External reference
Type 2 Diabetes Mellitus and Biomarkers of Neurodegeneration
10.1212/wnl.0000000000001982 · 2015 · External reference
Pre‐Diabetes, but Not Type 2 Diabetes, Is Related to Brain Amyloid in Late Middle‐Age
10.3233/jad-200232 · 2020 · External reference
Insulin Resistance Is Associated With the Pathology of Alzheimer Disease: The Hisayama Study
10.1212/wnl.0b013e3181eee25f · 2010 · External reference
Diabetes and Hypertension Are Related to Amyloid‐Beta Burden in the Population‐Based Rotterdam Study
10.1093/brain/awac354 · 2023 · External reference
Insulin Resistance Predicts Brain Amyloid Deposition in Late Middle‐Aged Adults
10.1016/j.jalz.2014.03.011 · 2015 · External reference
Amylin Deposition in the Brain: A Second Amyloid in Alzheimer Disease?
10.1002/ana.23956 · 2013 · External reference
Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets
10.3390/ijms232315287 · 2022 · External reference
Effects of Subcortical Atrophy and Alzheimer's Pathology on Cognition in Elderly Type 2 Diabetes: The Alzheimer's Disease Neuroimaging Initiative Study
10.3389/fnagi.2022.781938 · 2022 · External reference
The Association of Diabetes Mellitus With Amyloid and Tau Biomarkers
2025 · External reference
Amyloid and Tau Positron Emission Tomography in Suggested Diabetesrelated Dementia
10.2174/1567205015666180709113338 · 2018 · External reference
Impact of Diabetes on the Progression of Alzheimer's Disease via Trajectories of Amyloid‐Tau‐Neurodegeneration (ATN) Biomarkers
10.1016/j.jnha.2024.100444 · 2025 · External reference
Associations Between Glucose Metabolism Measures and Amyloid‐Beta and Tau Load on PET 14 Years Later: Findings From the Framingham Heart Study
10.2337/dc24-0162 · 2024 · External reference
Diabetes and the Brain: Oxidative Stress, Inflammation, and Autophagy
10.1155/2014/102158 · 2014 · External reference
A Cellular Perspective on Brain Energy Metabolism and Functional Imaging
10.1016/j.neuron.2015.03.035 · 2015 · External reference
Effect of Diabetes on Levels of Lipid Peroxides and Glycolipids in Rat Brain
10.1016/0026-0495(93)90195-t · 1993 · External reference
Antioxidant Defense Systems in the Brains of Type II Diabetic Mice
10.1046/j.1471-4159.1995.65010287.x · 1995 · External reference
CR‐6 Protects Glutathione Peroxidase Activity in Experimental Diabetes
10.1016/j.freeradbiomed.2007.08.001 · 2007 · External reference
Mitochondrial Dysfunction Plays a Key Role in the Development of Neurodegenerative Diseases in Diabetes
10.1152/ajpendo.00179.2019 · 2020 · External reference
The Role of Mitochondrial Quality Control in Cognitive Dysfunction in Diabetes
10.1007/s11064-022-03631-y · 2022 · External reference
Mitochondrial Dysfunction in Type 2 Diabetes Mellitus: An Organ‐Based Analysis
10.1152/ajpendo.00314.2018 · 2019 · External reference
Human Brain and Serum Advanced Glycation End Products Are Highly Correlated: Preliminary Results of Their Role in Alzheimer Disease and Type 2 Diabetes
10.4158/1934-2403-26.5.576 · 2020 · External reference
Serum Levels of Advanced Glycation End Products Are Increased in Patients With Type 2 Diabetes and Coronary Heart Disease
10.2337/diacare.22.9.1543 · 1999 · External reference
High Serum Advanced Glycation End Products Are Associated With Decreased Insulin Secretion in Patients With Type 2 Diabetes: A Brief Report
10.1155/2017/5139750 · 2017 · External reference
Pivotal Role of AGE‐RAGE Axis in Brain Aging With Current Interventions
10.1016/j.arr.2024.102429 · 2024 · External reference
Advanced Glycation End Products Enhance Macrophages Polarization Into M1 Phenotype Through Activating RAGE/NF‐kappaB Pathway
2015 · External reference
RAGE Inhibitors in Neurodegenerative Diseases
2023 · External reference
Roles of the Receptor for Advanced Glycation End Products and Its Ligands in the Pathogenesis of Alzheimer's Disease
10.3390/ijms26010403 · 2025 · External reference
Cytotoxicity of Advanced Glycation Endproducts in Human Micro‐ and Astroglial Cell Lines Depends on the Degree of Protein Glycation
10.1007/s00702-008-0126-4 · 2008 · External reference
AGEs Induce Alzheimer‐Like Tau Pathology and Memory Deficit via RAGE‐Mediated GSK‐3 Activation
10.1016/j.neurobiolaging.2011.02.003 · 2012 · External reference
RAGE‐Specific Inhibitor FPS‐ZM1 Attenuates AGEs‐Induced Neuroinflammation and Oxidative Stress in Rat Primary Microglia
10.1007/s11064-017-2321-x · 2017 · External reference
Advanced Glycation End Products Induce Microglial Activation and Impair Neurodevelopment in Human iPSC‐Derived Brain Organoids
10.3390/organoids5020012 · 2026 · External reference
The Role of GSK3 in Glucose Homeostasis and the Development of Insulin Resistance
10.1016/j.diabres.2007.01.033 · 2007 · External reference
Advanced Glycation End Products and Insulin Resistance
10.2174/138161208784139747 · 2008 · External reference
Microglial Activation and Polarization in Type 2 Diabetes‐Related Cognitive Impairment: A Focused Review of Pathogenesis
10.1016/j.neubiorev.2024.105848 · 2024 · External reference
Genipin Attenuates Diabetic Cognitive Impairment by Reducing Lipid Accumulation and Promoting Mitochondrial Fusion via FABP4/Mfn1 Signaling in Microglia
10.3390/antiox12010074 · 2022 · External reference
Nonenzymatic Function of DPP4 Promotes Diabetes‐Associated Cognitive Dysfunction Through IGF‐2R/PKA/SP1/ERp29/IP3R2 Pathway‐Mediated Impairment of Treg Function and M1 Microglia Polarization
10.1016/j.metabol.2022.155340 · 2023 · External reference
Hippocampal Overexpression of TREM2 Ameliorates High Fat Diet Induced Cognitive Impairment and Modulates Phenotypic Polarization of the Microglia
10.1016/j.gendis.2020.05.005 · 2022 · External reference
Fingolimod Alleviates Cognitive Deficit in Type 2 Diabetes by Promoting Microglial M2 Polarization via the pSTAT3‐jmjd3 Axis
10.1007/s12035-022-03120-x · 2023 · External reference
Effect of Dietary Exposure to Acrylamide on Diabetes‐Associated Cognitive Dysfunction From the Perspectives of Oxidative Damage, Neuroinflammation, and Metabolic Disorders
10.1021/acs.jafc.2c00662 · 2022 · External reference
Insulin Resistance and Body Mass Index Are Associated With TSPO PET in Cognitively Unimpaired Elderly
10.1177/0271678x231172519 · 2023 · External reference
Association of Early Beta‐Amyloid Accumulation and Neuroinflammation Measured With [(11)C]PBR28 in Elderly Individuals Without Dementia
10.1212/wnl.0000000000011612 · 2021 · External reference
PET Imaging of Neuroinflammation in Neurological Disorders
10.1016/s1474-4422(20)30346-x · 2020 · External reference
Microglia Measured by TSPO PET Are Associated With Alzheimer's Disease Pathology and Mediate Key Steps in a Disease Progression Model
10.1002/alz.13699 · 2024 · External reference
Ferroptosis in Cognitive Impairment Associated With Diabetes and Alzheimer's Disease: Mechanistic Insights and New Therapeutic Opportunities
10.1007/s12035-024-04417-9 · 2025 · External reference
Postmortem MRI and Histology Demonstrate Differential Iron Accumulation and Cortical Myelin Organization in Early‐ and Late‐Onset Alzheimer's Disease
10.1016/j.neurobiolaging.2017.10.017 · 2018 · External reference
Brain Iron Deposition in Type 2 Diabetes Mellitus With and Without Mild Cognitive Impairment‐An In Vivo Susceptibility Mapping Study
10.1007/s11682-017-9815-7 · 2018 · External reference
Iron and Alzheimer's Disease: From Pathology to Imaging
10.3389/fnhum.2022.838692 · 2022 · External reference
Cortical Iron Reflects Severity of Alzheimer's Disease
10.3233/jad-161143 · 2017 · External reference
Insulin Modulates Hippocampal Activity‐Dependent Synaptic Plasticity in a N‐Methyl‐d‐Aspartate Receptor and Phosphatidyl‐Inositol‐3‐Kinase‐Dependent Manner
10.1111/j.1471-4159.2005.03269.x · 2005 · External reference
Analysis of Metabolic Alterations Related to Pathogenic Process of Diabetic Encephalopathy Rats
10.3389/fncel.2018.00527 · 2018 · External reference
Impact of Insulin and Insulin Resistance on Brain Dopamine Signalling and Reward Processing—An Underexplored Mechanism in the Pathophysiology of Depression?
10.1016/j.neubiorev.2023.105179 · 2023 · External reference
Type 2 Diabetes Mellitus Accelerates Brain Aging and Cognitive Decline: Complementary Findings From UK Biobank and Meta‐Analyses
10.7554/elife.73138 · 2022 · External reference
The Association of Epigenetic Clocks in Brain Tissue With Brain Pathologies and Common Aging Phenotypes
10.1016/j.nbd.2021.105428 · 2021 · External reference
Aging the Brain: Multi‐Region Methylation Principal Component Based Clock in the Context of Alzheimer's Disease
10.18632/aging.204196 · 2022 · External reference
Blood Methylomic Signatures of Presymptomatic Dementia in Elderly Subjects With Type 2 Diabetes Mellitus
10.1016/j.neurobiolaging.2014.12.023 · 2015 · External reference
Reduced Telomere Length in Subjects With Dementia and Diabetes Mellitus Type 2 Is Independent of Apolipoprotein E4 Genotype
10.1016/j.ajp.2014.06.012 · 2014 · External reference
Glymphatic Failure as a Final Common Pathway to Dementia
10.1126/science.abb8739 · 2020 · External reference
Glymphatic System in Neurological Disorders and Implications for Brain Health
10.3389/fneur.2025.1543725 · 2025 · External reference
The Glymphatic System Clears Amyloid Beta and Tau From Brain to Plasma in Humans
10.1038/s41467-026-68374-8 · 2026 · External reference
The Glymphatic Response to the Development of Type 2 Diabetes
2024 · External reference
Impairment of the Glymphatic System After Diabetes
10.1177/0271678x16654702 · 2017 · External reference
Peripheral Origin Exosomal microRNAs Aggravate Glymphatic System Dysfunction in Diabetic Cognitive Impairment
10.1016/j.apsb.2023.03.018 · 2023 · External reference
Glymphatic Function and Its Influencing Factors in Different Glucose Metabolism States
10.4239/wjd.v15.i7.1537 · 2024 · External reference
Assessing Interstitial Fluid Dynamics in Type 2 Diabetes Mellitus and Prediabetes Cases Through Diffusion Tensor Imaging Analysis Along the Perivascular Space
10.3389/fnagi.2024.1362457 · 2024 · External reference
Evaluation of Glymphatic System Using Diffusion MR Technique in T2DM Cases
10.3389/fnhum.2020.00300 · 2020 · External reference
Anti‐Inflammatory Effects of GLP‐1 Receptor Activation in the Brain in Neurodegenerative Diseases
10.3390/ijms23179583 · 2022 · External reference
Pleiotropic Effects of GLP‐1 and Analogs on Cell Signaling, Metabolism, and Function
10.3389/fendo.2018.00672 · 2018 · External reference
Unresolved reference
External reference
An Atlas of the Protein‐Coding Genes in the Human, Pig, and Mouse Brain
10.1126/science.aay5947 · 2020 · External reference
Liraglutide Reduces Vascular Damage, Neuronal Loss, and Cognitive Impairment in a Mixed Murine Model of Alzheimer's Disease and Type 2 Diabetes
10.3389/fnagi.2021.741923 · 2021 · External reference
Liraglutide and a Lipidized Analog of Prolactin‐Releasing Peptide Show Neuroprotective Effects in a Mouse Model of Beta‐Amyloid Pathology
10.1016/j.neuropharm.2018.11.002 · 2019 · External reference
Liraglutide Can Reverse Memory Impairment, Synaptic Loss and Reduce Plaque Load in Aged APP/PS1 Mice, a Model of Alzheimer's Disease
10.1016/j.neuropharm.2013.08.005 · 2014 · External reference
The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel With Decreasing Both Amyloid‐Beta Plaque and Glial Pathology in a Mouse Model of Alzheimer's Disease
10.1007/s12017-012-8199-5 · 2013 · External reference
Cardioprotective Glucose‐Lowering Agents and Dementia Risk: A Systematic Review and Meta‐Analysis
10.1001/jamaneurol.2025.0360 · 2025 · External reference
Efficacy and Safety of Oral Semaglutide 14 mg (Flexible Dose) in Early‐Stage Symptomatic Alzheimer's Disease (Evoke and Evoke+): Two Phase 3, Randomised, Placebo‐Controlled Trials
10.1016/s0140-6736(26)00459-9 · 2026 · External reference
The Role of SGLT1 and GLUT2 in Intestinal Glucose Transport and Sensing
10.1371/journal.pone.0089977 · 2014 · External reference
Cognitive Impairment and Type 2 Diabetes Mellitus: Focus of SGLT2 Inhibitors Treatment
10.1016/j.phrs.2022.106062 · 2022 · External reference
Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
10.1161/jaha.120.018889 · 2020 · External reference
Dapagliflozin in Patients With Chronic Kidney Disease
10.1056/nejmoa2024816 · 2020 · External reference
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
10.1056/nejmoa1504720 · 2015 · External reference
GLP‐1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias
10.1001/jamaneurol.2025.0353 · 2025 · External reference
Treatment With Glucagon‐Like Peptide‐1 Receptor Agonists and Incidence of Dementia: Data From Pooled Double‐Blind Randomized Controlled Trials and Nationwide Disease and Prescription Registers
10.1002/trc2.12268 · 2022 · External reference
Neuroprotective Effects of GLP‐1 Receptor Agonists in Neurodegenerative Disorders: A Large‐Scale Propensity‐Matched Cohort Study
10.1016/j.intimp.2024.113537 · 2024 · External reference
Liraglutide in Mild to Moderate Alzheimer's Disease: A Phase 2b Clinical Trial
10.1038/s41591-025-04106-7 · 2026 · External reference
Sodium‐Glucose Cotransporter‐2 Inhibitors and Their Potential Role in Dementia Onset and Cognitive Function in Patients With Diabetes Mellitus: A Systematic Review and Meta‐Analysis
10.1016/j.yfrne.2024.101131 · 2024 · External reference
Association of Sodium‐Glucose Cotransporter 2 Inhibitors With Time to Dementia: A Population‐Based Cohort Study
10.2337/dc22-1705 · 2023 · External reference
Sodium‐Glucose Cotransporter 2 (SGLT2) Inhibitors vs. Dipeptidyl Peptidase‐4 (DPP4) Inhibitors for New‐Onset Dementia: A Propensity Score‐Matched Population‐Based Study With Competing Risk Analysis
10.3389/fcvm.2021.747620 · 2021 · External reference
Cerebrovascular, Cognitive and Cardiac Benefits of SGLT2 Inhibitors Therapy in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: Results From a Global Federated Health Network Analysis
10.3390/jcm12082814 · 2023 · External reference
The Association Between Sodium‐Glucose Cotransporter 2 Inhibitors and Incident Dementia: A Nationwide Population‐Based Longitudinal Cohort Study
10.1177/14791641221098168 · 2022 · External reference
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
10.1212/wnl.0000000000209805 · 2024 · External reference
Intranasal Insulin for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
10.1016/j.neurol.2025.11.005 · 2026 · External reference
MemAID: Memory Advancement With Intranasal Insulin vs. Placebo in Type 2 Diabetes and Control Participants: A Randomized Clinical Trial
10.1007/s00415-022-11119-6 · 2022 · External reference
Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial
10.1001/jama.2018.21442 · 2019 · External reference
The Relation Between Antihypertensive Treatment and Progression of Cerebral Small Vessel Disease: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
10.1097/md.0000000000026749 · 2021 · External reference
Effects of Aspirin on Dementia and Cognitive Function in Diabetic Patients: The ASCEND Trial
10.1093/eurheartj/ehac179 · 2022 · External reference
Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
10.1161/str.0000000000000116 · 2017 · External reference
Statins Use and Risk of Dementia: A Dose‐Response Meta Analysis
10.1097/md.0000000000011304 · 2018 · External reference
Current and Emerging Therapeutic Approaches for Vascular Cognitive Impairment and Dementia
10.1016/j.jacc.2025.09.1502 · 2026 · External reference
Development of Azeliragon, an Oral Small Molecule Antagonist of the Receptor for Advanced Glycation Endproducts, for the Potential Slowing of Loss of Cognition in Mild Alzheimer's Disease
10.14283/jpad.2018.18 · 2018 · External reference
Unresolved reference
External reference
10.1101/2025.04.30.25326602
10.1101/2025.04.30.25326602 · External reference
Dampening of Microglial Activation With Nasal Foralumab Administration in Moderate Alzheimer's Disease Dementia
10.1097/rlu.0000000000005955 · 2025 · External reference
Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double‐Blind and Controlled Trial
10.3389/fnagi.2016.00256 · 2016 · External reference
Does Severity of Alzheimer's Disease Contribute to Its Responsiveness to Modifying Gut Microbiota? A Double Blind Clinical Trial
10.3389/fneur.2018.00662 · 2018 · External reference
Probiotics Supplementation and Brain‐Derived Neurotrophic Factor (BDNF): A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
10.1080/1028415x.2022.2110664 · 2023 · External reference
Brain Responses to Intermittent Fasting and the Healthy Living Diet in Older Adults
10.1016/j.cmet.2024.05.017 · 2024 · External reference
Effects of Intermittent Fasting on Body Composition, Clinical Health Markers and Memory Status in the Adult Population: A Single‐Blind Randomised Controlled Trial
10.1186/s12937-024-01046-9 · 2024 · External reference
Effects of Ketogenic Diet on Cognitive Function of Patients With Alzheimer's Disease: A Systematic Review and Meta‐Analysis
10.1016/j.jnha.2024.100306 · 2024 · External reference
Impact of Bodyweight Loss on Type 2 Diabetes Remission: A Systematic Review and Meta‐Regression Analysis of Randomised Controlled Trials
10.1016/s2213-8587(24)00346-2 · 2025 · External reference
Intranasal Insulin
10.1111/jne.12934 · 2021 · External reference
Effects of Intranasal Insulin Administration on Cerebral Blood Flow and Cognitive Performance in Adults: A Systematic Review of Randomized
2023 · External reference
Safety and Efficacy of Intranasal Insulin in Patients With Alzheimer's Disease: A Systematic Review and Meta‐Analysis
10.18053/jctres.09.202304.23-00013 · 2023 · External reference
Outcomes and Clinical Implications of Intranasal Insulin on Cognition in Humans: A Systematic Review and Meta‐Analysis
10.1371/journal.pone.0286887 · 2023 · External reference
Antithrombotic Therapy to Prevent Cognitive Decline in People With Small Vessel Disease on Neuroimaging but Without Dementia
2022 · External reference
Longitudinal Study on Low‐Dose Aspirin Versus Placebo Administration in Silent Brain Infarcts: The Silence Study
10.1155/2018/7532403 · 2018 · External reference
Targeted Inhibition of RAGE Reduces Amyloid‐Beta Influx Across the Blood‐Brain Barrier and Improves Cognitive Deficits in db/db Mice
10.1016/j.neuropharm.2017.12.026 · 2018 · External reference
P3‐032: Efficacy of Rage Antagonists in Murine Model of Alzheimer's Disease
2014 · External reference
Targeting Microglia in Alzheimer's Disease: Pathogenesis and Potential Therapeutic Strategies
10.3390/biom14070833 · 2024 · External reference
Nasal Administration of Anti‐CD3 Monoclonal Antibody Ameliorates Disease in a Mouse Model of Alzheimer's Disease
10.1073/pnas.2309221120 · 2023 · External reference
IL‐10‐Dependent Tr1 Cells Attenuate Astrocyte Activation and Ameliorate Chronic Central Nervous System Inflammation
10.1093/brain/aww113 · 2016 · External reference
Gut Microbiota in Type 2 Diabetes Mellitus: Mechanistic Links Between Dysbiosis, Insulin Resistance, and Chronic Low‐Grade Inflammation
10.3389/fendo.2026.1856667 · 2026 · External reference
A Systematic Review on Gut Microbiota in Type 2 Diabetes Mellitus
10.3389/fendo.2024.1486793 · 2024 · External reference
Prediction of Functional Profiles of Gut Microbiota From 16S rRNA Metagenomic Data Provides a More Robust Evaluation of Gut Dysbiosis Occurring in Japanese Type 2 Diabetic Patients
10.3164/jcbn.17-44 · 2017 · External reference
Comprehensive Relationships Between Gut Microbiome and Faecal Metabolome in Individuals With Type 2 Diabetes and Its Complications
10.1007/s12020-019-02103-8 · 2019 · External reference
The Impact of Microbiota‐Gut‐Brain Axis on Diabetic Cognition Impairment
10.3389/fnagi.2017.00106 · 2017 · External reference
Short‐Chain Fatty Acids Mediate Gut Microbiota‐Brain Communication and Protect the Blood‐Brain Barrier Integrity
10.1111/nyas.15299 · 2025 · External reference
The Role of Short‐Chain Fatty Acids in Microbiota‐Gut‐Brain Communication
10.1038/s41575-019-0157-3 · 2019 · External reference
Association of Gut Microbiota With Sort‐Chain Fatty Acids and Inflammatory Cytokines in Diabetic Patients With Cognitive Impairment: A Cross‐Sectional, Non‐Controlled Study
10.3389/fnut.2022.930626 · 2022 · External reference
Early Changes of Fecal Short‐Chain Fatty Acid Levels in Patients With Mild Cognitive Impairments
10.1111/cns.14252 · 2023 · External reference
Serum Short‐Chain Fatty Acid Profiles as Metabolic Signatures of Diabetic Cognitive Impairment: Multinomial Modelling and Internally Validated Multiclass Discrimination
10.1111/dom.70656 · 2026 · External reference
The Effects of Probiotic Supplements on Oxidative Stress and Inflammation in Subjects With Mild and Moderate Alzheimer's Disease: A Randomized, Double‐Blind, Placebo‐Controlled Study
10.1007/s10787-023-01427-2 · 2024 · External reference
The Effects of Probiotics Supplementation on Glycaemic Control Among Adults With Type 2 Diabetes Mellitus: A Systematic Review and Meta‐Analysis of Randomised Clinical Trials
10.1186/s12967-023-04306-0 · 2023 · External reference
Effects of a 6‐Month Multi‐Strain Probiotics Supplementation in Endotoxemic, Inflammatory and Cardiometabolic Status of T2DM Patients: A Randomized, Double‐Blind, Placebo‐Controlled Trial
10.1016/j.clnu.2018.08.009 · 2019 · External reference
Increased Tau Phosphorylation and Impaired Brain Insulin/IGF Signaling in Mice Fed a High Fat/High Cholesterol Diet
10.3233/jad-2012-121030 · 2013 · External reference
Microglia/Macrophage‐Specific Deletion of TLR‐4 Protects Against Neural Effects of Diet‐Induced Obesity in a Sexually Dimorphic Manner
10.1186/s12974-025-03534-z · 2025 · External reference
Effect of High‐Fat Diets on Oxidative Stress, Cellular Inflammatory Response and Cognitive Function
10.3390/nu11112579 · 2019 · External reference
Dietary Fat Intake and 6‐Year Cognitive Change in an Older Biracial Community Population
10.1212/01.wnl.0000123250.82849.b6 · 2004 · External reference
Dietary Fat Types and 4‐Year Cognitive Change in Community‐Dwelling Older Women
10.1002/ana.23593 · 2012 · External reference
Association Between Dietary Fat Intake and Long‐Term Risk of Dementia: A Prospective Cohort Study
10.1016/j.ajcnut.2025.09.028 · 2025 · External reference
The Effects of Intermittent Fasting on Brain and Cognitive Function
10.3390/nu13093166 · 2021 · External reference
Intermittent Metabolic Switching, Neuroplasticity and Brain Health
10.1038/nrn.2017.156 · 2018 · External reference
Gut Microbiota Mediates Intermittent‐Fasting Alleviation of Diabetes‐Induced Cognitive Impairment
10.1038/s41467-020-14676-4 · 2020 · External reference
Intermittent Fasting Protects Against Alzheimer's Disease in Mice by Altering Metabolism Through Remodeling of the Gut Microbiota
10.1038/s43587-022-00311-y · 2022 · External reference
The Impact of Continuous Calorie Restriction and Fasting on Cognition in Adults Without Eating Disorders
10.1093/nutrit/nuad170 · 2025 · External reference
5. Facilitating Positive Health Behaviors and Well‐Being to Improve Health Outcomes: Standards of Care in Diabetes‐2024
10.2337/dc24-s005 · 2024 · External reference
The Effects of Intermittent Fasting on Body Composition and Cardiometabolic Health in Adults With Prediabetes or Type 2 Diabetes: A Systematic Review and Meta‐Analysis
10.1111/dom.15730 · 2024 · External reference
Very Low Carbohydrate (Ketogenic) Diets in Type 2 Diabetes: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
10.1111/dom.14837 · 2022 · External reference
Effects of Dietary Approaches to Stop Hypertension (DASH) Diet on Some Risk for Developing Type 2 Diabetes: A Systematic Review and Meta‐Analysis on Controlled Clinical Trials
10.1016/j.nut.2012.12.021 · 2013 · External reference
Impact of the Mediterranean Diet on Glycemic Control, Body Mass Index, Lipid Profile, and Blood Pressure in Type 2 Diabetes: A Meta‐Analysis of Randomized Controlled Trials
10.3390/nu17243908 · 2025 · External reference
The Role of Autophagy in the Treatment of Type II Diabetes and Its Complications: A Review
10.3389/fendo.2023.1228045 · 2023 · External reference
The Neuroprotective Role of Humanin in Alzheimer's Disease: The Molecular Effects
10.1016/j.ejphar.2025.177510 · 2025 · External reference
HIF‐1alpha Serves as a Co‐Linker Between AD and T2DM
10.1016/j.biopha.2024.116158 · 2024 · External reference
127‐OR: Identification of Exosomal miRNA as a Novel Causal Biomarker for Cognitive Impairment in Type 2 Diabetes Mellitus—Triangulating Evidence From Mendelian Randomization Analyses and Multicenter Cohort
10.2337/db24-127-or · 2024 · External reference
The Overexpression of miR‐146a in Hippocampal Microglia via IRAK1/TRAF6/NF‐kappaB Pathway Improves Cognitive Function in Diabetic Mice
10.1016/j.expneurol.2025.115291 · 2025 · External reference
A Broader View of Dementia: Multiple Co‐Pathologies Are the Norm
10.1093/brain/awy153 · 2018 · External reference
